Lipostructure technique in Romberg syndrome.
Progressive hemifacial atrophy, also known as Parry-Romberg syndrome, is an uncommon degenerative and poorly understood condition. It is characterized by a slow and progressive atrophy affecting one side of the face. The incidence and the cause of this alteration are unknown. Pathogenesis of this syndrome is not clear: some authors refer the atrophy of subcutaneous system to the alteration of sympathetic system, whereas others refer it to an alteration of the nervous system referred to the encephalic level or to an interstitial neuritis of the trigeminal nerve. The most common complications that appear in association to this health disorder are as follows: trigeminal neuritis, facial, and epilepsy, the last one being the most frequent complication of the central nervous system. Characteristically, the atrophy progresses slowly for several years, and soon after, it becomes stable. Today, plastic surgery with graft of autogenous fat can be performed after stabilization of the disease. The objective of this work is, through the presentation of a clinical case, suggesting a therapeutic plan formed by 2 sequential treatments: poliglactic acid to obtain skin thickening followed by Coleman technique for reconstructing three-dimensional projection of face contour restoring the superficial density of facial tissues. The results we obtained prove the efficacy of combining these 2 treatments, and the satisfaction of the patient confirms the quality of our results.
Grimaldi
Monica
M
Department of Plastic and Reconstructive Surgery, Policlinico Casilino University Tor Vergata, Rome, Italy.
Gentile
Pietro
P
Labardi
Lara
L
Silvi
Ermina
E
Trimarco
Anna
A
Cervelli
Valerio
V
D050153:Abdominal Fat / Q000166:cytology / Q000637:transplantation; D017667:Adipocytes / Q000637:transplantation*; D017690:Cell Transplantation / Q000379:methods*; D002482:Cellulose / Q000008:administration & dosage; D003357:Cosmetic Techniques; D003879:Dermatologic Agents / Q000008:administration & dosage; D005150:Facial Hemiatrophy / Q000601:surgery*; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D019344:Lactic Acid / Q000008:administration & dosage; D008353:Mannitol / Q000008:administration & dosage; D008875:Middle Aged; D054457:Tissue Scaffolds; D020858:Tissue and Organ Harvesting / Q000379:methods; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D003879:Dermatologic Agents; C482305:New-Fill; D019344:Lactic Acid; D008353:Mannitol; D002482:Cellulose